You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anifrolumab

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous Lupus Erythematosus Trial (Anifrolumab, Placebo)

Not yet recruiting
  • Cutaneous Lupus Erythematosus
  • Anifrolumab
  • Placebo
  • (no location specified)
Aug 22, 2023

Systemic Lupus Erythematosus Trial (Anifrolumab, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Anifrolumab
  • Placebo
  • (no location specified)
Apr 18, 2023

Among SLE Patients Receiving Anifrolumab in Routine Clinical

Not yet recruiting
  • Systemic Lupus Erythematosus
  • None (Observational study)
  • (no location specified)
Nov 24, 2022

SLE Patients Treated With Anifrolumab in Early Access Programs

Not yet recruiting
  • Systemic Lupus Erythematosus
  • None (Observational study)
  • (no location specified)
Sep 13, 2023

Healthy Participants Study Trial in Brooklyn, Berlin, Harrow (Anifrolumab, Autoinjector, Accessorized Pre-Filled Syringe)

Recruiting
  • Healthy Participants Study
  • Anifrolumab
  • +2 more
  • Brooklyn, Maryland
  • +2 more
Dec 22, 2022

Vitiligo Trial in France (Anifrolumab Infusion Product, Placebo)

Not yet recruiting
  • Vitiligo
  • Anifrolumab Infusion Product
  • Placebo
  • Bordeaux, France
  • +3 more
Jun 14, 2023

Sjogren's Syndrome Trial (Anifrolumab)

Recruiting
  • Sjogren's Syndrome
  • Anifrolumab
  • Placebo
  • Groningen, Netherlands
    University Medical Centre Groningen
Dec 16, 2022

Systemic Lupus Erythematosus Trial in Nantong, Shanghai (Anifrolumab)

Completed
  • Systemic Lupus Erythematosus
  • Anifrolumab
  • Nantong, China
  • +2 more
Aug 17, 2022

Systemic Lupus Erythematosus, Cardiovascular Disease, Premature Atherosclerosis Trial run by the National Institute of Arthritis

Not yet recruiting
  • Systemic Lupus Erythematosus
  • +2 more
  • anifrolumab
  • Placebo
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Systemic Lupus Erythematosus (SLE) Trial in United States (Anifrolumab, Standard of Care)

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • Anifrolumab
  • Standard of Care
  • New Haven, Connecticut
  • +4 more
Nov 18, 2021

Systemic Lupus Erythematosus Trial (Anifrolumab)

No longer available
  • Systemic Lupus Erythematosus
  • Anifrolumab
  • (no location specified)
May 4, 2021

Active Systemic Lupus Erythematosus Trial in Worldwide (Anifrolumab, )

Recruiting
  • Active Systemic Lupus Erythematosus
  • Anifrolumab
  • placebo
  • Baoding, China
  • +71 more
Jan 13, 2023

Systemic Sclerosis, Scleroderma Trial in Worldwide (Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open

Not yet recruiting
  • Systemic Sclerosis
  • Scleroderma
  • Anifrolumab (blinded)
  • +2 more
  • Birmingham, Alabama
  • +130 more
Jun 22, 2023

Lupus Nephritis Trial in Worldwide (Anifrolumab, Placebo)

Recruiting
  • Lupus Nephritis
  • Anifrolumab
  • Placebo
  • Phoenix, Arizona
  • +135 more
Jan 11, 2023

Lupus Nephritis Trial in Worldwide (Anifrolumab, Placebo)

Completed
Has Results
  • Lupus Nephritis
  • Anifrolumab
  • Placebo
  • Glendale, Arizona
  • +79 more
Oct 28, 2021

Active Systemic Lupus Erythematosus Trial in Worldwide (Anifrolumab, Placebo)

Completed
Has Results
  • Active Systemic Lupus Erythematosus
  • Anifrolumab
  • Placebo
  • Birmingham, Alabama
  • +174 more
Dec 19, 2022

Systemic Lupus Erythematosus Trial in Worldwide (Medi-546, Placebo)

Recruiting
  • Systemic Lupus Erythematosus
  • Anniston, Alabama
  • +156 more
Jan 11, 2023

Rheumatoid Arthritis Trial in Graz, Wien (Anifrolumab, Placebos)

Unknown status
  • Rheumatoid Arthritis
  • Anifrolumab
  • Placebos
  • Graz, Austria
  • +2 more
Feb 27, 2020

Systemic Lupus Erythematosus Trial in Worldwide (Anifrolumab, Placebo)

Completed
Has Results
  • Systemic Lupus Erythematosus
  • Anifrolumab
  • Placebo
  • Thousand Oaks, California
  • +13 more
Dec 16, 2019

SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing

Recruiting
  • Lupus Erythematosus, Systemic
    • Aichi, Japan
    • +93 more
    Jan 24, 2023

    Safety, Pharmacokinetics, Healthy Subjects Trial in Baltimore (Anifrolumab SC injection (300mg), Anifrolumab IV infusion

    Completed
    Has Results
    • Safety
    • +2 more
    • Anifrolumab SC injection (300mg)
    • +5 more
    • Baltimore, Maryland
      Research Site
    Feb 25, 2019

    Active Systemic Lupus Erythematosus Trial in Worldwide (Anifrolumab, Placebo)

    Completed
    Has Results
    • Active Systemic Lupus Erythematosus
    • Anifrolumab
    • Placebo
    • Covina, California
    • +112 more
    Apr 10, 2020

    Active Systemic Lupus Erythematosus Trial in Worldwide (Anifrolumab, Placebo)

    Completed
    Has Results
    • Active Systemic Lupus Erythematosus
    • Anifrolumab
    • Placebo
    • Birmingham, Alabama
    • +145 more
    Nov 18, 2019

    Lupus Erythematosus, Systemic Trial in Worldwide (Anifrolumab)

    Completed
    Has Results
    • Lupus Erythematosus, Systemic
    • Anifrolumab
    • Birmingham, Alabama
    • +56 more
    Jul 11, 2019

    COVID-19 Trial in Worldwide (AZD7442, Placebo)

    Active, not recruiting
    Has Results
    • COVID-19
    • Birmingham, Alabama
    • +85 more
    Nov 25, 2022